Barclays PLC Acquires 104,305 Shares of Owens & Minor, Inc. (NYSE:OMI)

Barclays PLC lifted its stake in shares of Owens & Minor, Inc. (NYSE:OMI - Free Report) by 354.8% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 133,702 shares of the company's stock after buying an additional 104,305 shares during the quarter. Barclays PLC owned about 0.17% of Owens & Minor worth $2,099,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Royce & Associates LP raised its stake in shares of Owens & Minor by 179.4% in the third quarter. Royce & Associates LP now owns 80,914 shares of the company's stock worth $1,270,000 after purchasing an additional 51,955 shares during the last quarter. Deerfield Management Company L.P. Series C grew its position in Owens & Minor by 30.6% during the second quarter. Deerfield Management Company L.P. Series C now owns 6,371,440 shares of the company's stock valued at $86,014,000 after buying an additional 1,493,852 shares during the period. Renaissance Technologies LLC increased its stake in shares of Owens & Minor by 16.5% during the 2nd quarter. Renaissance Technologies LLC now owns 1,246,600 shares of the company's stock worth $16,829,000 after purchasing an additional 176,250 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Owens & Minor by 1.7% in the second quarter. Dimensional Fund Advisors LP now owns 4,534,204 shares of the company's stock valued at $61,213,000 after buying an additional 76,599 shares during the period. Finally, FMR LLC lifted its holdings in Owens & Minor by 0.8% during the third quarter. FMR LLC now owns 11,564,624 shares of the company's stock valued at $181,449,000 after purchasing an additional 90,862 shares during the last quarter. Institutional investors own 98.04% of the company's stock.

Owens & Minor Trading Down 0.2 %

OMI traded down $0.02 during midday trading on Friday, reaching $12.95. 637,020 shares of the company's stock traded hands, compared to its average volume of 804,284. The stock has a market capitalization of $998.56 million, a price-to-earnings ratio of -19.92, a P/E/G ratio of 0.48 and a beta of 0.42. Owens & Minor, Inc. has a 52 week low of $11.42 and a 52 week high of $28.35. The firm has a fifty day moving average of $13.15 and a two-hundred day moving average of $14.43. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45.

Owens & Minor (NYSE:OMI - Get Free Report) last announced its quarterly earnings results on Monday, November 4th. The company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.41 by $0.01. The company had revenue of $2.72 billion for the quarter, compared to analysts' expectations of $2.68 billion. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. Owens & Minor's quarterly revenue was up 5.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.44 earnings per share. On average, equities analysts anticipate that Owens & Minor, Inc. will post 1.49 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the company. Robert W. Baird cut their price target on Owens & Minor from $19.00 to $14.00 and set a "neutral" rating for the company in a report on Tuesday, November 5th. Barclays decreased their price target on shares of Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating on the stock in a report on Tuesday, November 5th. UBS Group cut their target price on shares of Owens & Minor from $28.00 to $25.00 and set a "buy" rating for the company in a research report on Tuesday, November 5th. Finally, Citigroup decreased their price target on shares of Owens & Minor from $21.00 to $18.50 and set a "buy" rating on the stock in a research note on Tuesday, November 5th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, Owens & Minor currently has an average rating of "Hold" and an average target price of $18.50.

Insider Transactions at Owens & Minor

In other news, CFO Jonathan A. Leon sold 5,282 shares of Owens & Minor stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $11.82, for a total transaction of $62,433.24. Following the completion of the transaction, the chief financial officer now directly owns 130,822 shares in the company, valued at approximately $1,546,316.04. This trade represents a 3.88 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 2.62% of the company's stock.

Owens & Minor Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.